Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Eric Mou"'
Autor:
Kaleb Veit, DO, Tahuanty Peña, MD, MS, Julia Klesney-Tait, MD, PhD, Eric Mou, MD, Umar Farooq, MD
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100101- (2024)
Chimeric antigen receptor T-cell therapy (CAR-T) has been used to treat refractory post-transplant lymphoproliferative disorder (PTLD) in solid organ transplant patients, including heart, kidney, liver, intestine, and pancreas. We report the use of C
Externí odkaz:
https://doaj.org/article/623aeb9d284540dc9ab60f84e30defda
Sezary syndrome initially presenting as pityriasis rubra pilaris: Clinicopathologic study of 3 cases
Publikováno v:
JAAD Case Reports, Vol 44, Iss , Pp 101-106 (2024)
Externí odkaz:
https://doaj.org/article/5921e7a683dc4aec95e1fe9f70dc8ee2
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Cutaneous 5T cell lymphoma (CTCL), characterized by malignant T cells infiltrating the skin with potential for dissemination, remains a challenging disease to diagnose and treat due to disease heterogeneity, treatment resistance, and lack of effectiv
Externí odkaz:
https://doaj.org/article/bb4517254c3749119b35fec78a621d9d
Autor:
Henry Kwang, Eric Mou, Ilana Richman, Andre Kumar, Caroline Berube, Rajani Kaimal, Neera Ahuja, Stephanie Harman, Tyler Johnson, Neil Shah, Ronald Witteles, Robert Harrington, Lisa Shieh, Jason Hom
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Thrombophilia testing is frequently ordered in the inpatient setting despite its limited impact on clinical decision-making and unreliable results in the setting of acute thrombosis or ongoing anticoagulation. We sought to determi
Externí odkaz:
https://doaj.org/article/19bd124d8cd74f63845ee7eba08dddc5
Autor:
Megan J. Fitzpatrick, Vandana Sundaram, Amy Ly, Jeremy S. Abramson, Ronald Balassanian, Matthew C. Cheung, Stephen L. Cook, Lorenzo Falchi, Annabel K. Frank, Srishti Gupta, Robert P. Hasserjian, Oscar Lin, Steven R. Long, Joshua R. Menke, Eric Mou, Daniel R. Reed, Roberto Ruiz‐Cordero, Ashley K. Volaric, Linlin Wang, Kwun Wah Wen, Yi Xie, Sara L. Zadeh, Dita Gratzinger
Publikováno v:
Cancer Cytopathology. 131:279-288
Few studies have evaluated diagnostic yield of small volume biopsies (SVB) for the diagnosis and management of follicular lymphoma (FL).The authors performed a multi-institutional retrospective analysis of SVBs including fine-needle aspiration (FNA)
Autor:
Sanjal H. Desai, Raphael Mwangi, Wern Lynn Ng, Rebecca L. King, Matthew J. Maurer, James R. Cerhan, Andrew L. Feldman, Umar Farooq, Eric Mou, Thomas M. Habermann, Carrie A. Thompson, Yucai Wang, Thomas E. Witzig, Grzegorz S. Nowakowski
Publikováno v:
Blood Advances. 6:6180-6186
An enhanced understanding of the molecular heterogeneity of diffuse large B-cell lymphoma (DLBCL) has opened the door to clinical trials evaluating novel agents with subtype-specific activity. It is an emerging question whether core needle biopsies (
Autor:
Angie Mae Rodday, Susan K. Parsons, Jonathan W. Friedberg, Andrea Gallamini, Eliza Hawkes, David C. Hodgson, Peter Johnson, Brian K. Link, Eric Mou, Kerry J. Savage, Jenica Upshaw, Pier Luigi Zinzani, Matthew J. Maurer, Andrew M. Evens
Publikováno v:
Blood. 140:760-762
Autor:
Sanjal H Desai, Raphael Mwangi, Yucai Wang, Umar Farooq, Eric Mou, Andrew L. Feldman, Sergei Syrbu, Susan L. Slager, Grzegorz S. Nowakowski, Matthew J. Maurer, Neil E. Kay, Thomas M. Habermann, Brian K. Link, Carrie A. Thompson, James R. Cerhan
Publikováno v:
Blood. 140:1934-1936
Autor:
Jia Ruan, Melissa C. Larson, Zhengming Chen, N. Nora Bennani, Pamela B. Allen, David L Jaye, Jonathon B. Cohen, Dai Chihara, Francisco Vega, Giorgio Inghirami, Eric Mou, Carla Casulo, Neha Mehta-Shah, Peter Martin, Matthew J. Maurer, Brad S. Kahl, Izidore S. Lossos, Christopher R. Flowers, James R. Cerhan, Andrew L. Feldman
Publikováno v:
Blood. 140:3666-3668
Autor:
Angie Mae Rodday, Susan K. Parsons, Jenica N. Upshaw, Jonathan W. Friedberg, Andrea Gallamini, Eliza Hawkes, David Hodgson, Peter Johnson, Brian K. Link, Eric Mou, Kerry J. Savage, Pier Luigi Zinzani, Matthew Maurer, Andrew M. Evens
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
PURPOSE The International Prognostic Score (IPS) has been used in classic Hodgkin lymphoma (cHL) for 25 years. However, analyses have documented suboptimal performance of the IPS among contemporarily treated patients. Harnessing multisource individua